Role of Anti-Tuberculous Treatment in the Outcome of Decortication for Chronic Tuberculous Empyema
- PMID: 33575146
- PMCID: PMC7870130
- DOI: 10.7759/cureus.12583
Role of Anti-Tuberculous Treatment in the Outcome of Decortication for Chronic Tuberculous Empyema
Abstract
Introduction: Chronic tuberculous empyema (CTE) is a common complication of tuberculosis that requires some form of surgical intervention along with anti-tuberculosis therapy (ATT). The aim of this study was to determine the optimum duration of pre-operative ATT in CTE prior to the decortication and its outcomes.
Material and methods: This comparative prospective study was conducted from August 2019 to August 2020 in the Department of Thoracic Surgery, Jinnah Postgraduate Medical Centre, Karachi, Pakistan. A total of 70 patients were included in the study. They were grouped into two arms: patients operated at or within six weeks of ATT commencement (Group A) and patients operated after six weeks of ATT (Group B). Both groups had 35 participants each. Patients were evaluated based on a self-administered questionnaire. A p-value of less than 0.05 was considered significant.
Result: In this study, there were 55 (78.6%) males and 15 (21.4%) females with a mean age of 33.5 ± 11.2 years. Diagnosis of CTE was most commonly made through sputum acid-fast bacilli (AFB) smear (n=35, 50%) which most commonly involved right upper (n=20, 28.6%) and lower lung lobes (n=20, 28.6%). Complications such as air leaks, need for ventilator support, need for intensive care unit (ICU) stay, residual collection, and pneumothorax all were significantly higher in Group A (31 patients out of 35) compared to Group B (18 patients out of 35). In Group B, 21 (60%) participants had full post-operative expansion of lungs, compared to eight (22.8%) in Group A (p=0.002). In total five participants had failure to expand lungs; all of them belonged to Group A (p=0.02).
Conclusion: The optimum timing of surgery and preoperative ATT is crucial for achieving better outcomes and requires good collaboration between the treating pulmonologist and thoracic surgeon. Our study highlights the importance of pre-operative ATT for at least more than six weeks before undertaking decortication for better outcomes and minimizing morbidity.
Keywords: air leak; anti-tuberculous therapy; chronic tuberculous empyema; decortication; lung expansion; outcome.
Copyright © 2021, Sikander et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Early Functional Results of Surgery for Organizing Phase of Empyema Thoracis in a High Output Centre for Thoracic Surgery.Cureus. 2020 Dec 31;12(12):e12404. doi: 10.7759/cureus.12404. Cureus. 2020. PMID: 33532162 Free PMC article.
-
Thoracoscopic Decortication of Stage III Tuberculous Empyema Is Effective and Safe in Selected Cases.Ann Thorac Surg. 2017 Nov;104(5):1688-1694. doi: 10.1016/j.athoracsur.2017.06.038. Epub 2017 Sep 28. Ann Thorac Surg. 2017. PMID: 28964422
-
Treatment Outcomes of Tuberculous and Non-tuberculous Empyema Thoracis.J West Afr Coll Surg. 2020 Jan-Mar;10(1):15-19. doi: 10.4103/jwas.jwas_43_21. Epub 2022 Mar 5. J West Afr Coll Surg. 2020. PMID: 35531583 Free PMC article.
-
[Decortication in Pleural Empyema: Reasonable Effects on Lung Function?].Zentralbl Chir. 2016 Sep;141 Suppl 1:S18-25. doi: 10.1055/s-0042-112025. Epub 2016 Sep 8. Zentralbl Chir. 2016. PMID: 27607885 Review. German.
-
Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?Interact Cardiovasc Thorac Surg. 2010 Aug;11(2):171-7. doi: 10.1510/icvts.2010.240408. Epub 2010 May 3. Interact Cardiovasc Thorac Surg. 2010. PMID: 20439299 Review.
Cited by
-
The safety and efficacy of decortication for stage III drug-resistant tuberculous empyema.Interdiscip Cardiovasc Thorac Surg. 2023 Nov 2;37(5):ivad166. doi: 10.1093/icvts/ivad166. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37812210 Free PMC article.
-
Successful surgical treatment of bronchopleural fistula caused by severe pulmonary tuberculosis: A case report and review of literature.World J Clin Cases. 2023 Apr 6;11(10):2282-2289. doi: 10.12998/wjcc.v11.i10.2282. World J Clin Cases. 2023. PMID: 37122506 Free PMC article.
-
The efficacy and safety of uniportal video-assisted thoracic surgery on the treatment for stage II-III tuberculous empyema: a single-arm clinical retrospective study from 2016 to 2021 in a thoracic surgery center in China.BMC Pulm Med. 2022 Nov 3;22(1):398. doi: 10.1186/s12890-022-02182-w. BMC Pulm Med. 2022. PMID: 36329427 Free PMC article.
-
A nomogram to predict residual cavity formation after thoracoscopic decortication in chronic tuberculous empyema.Interact Cardiovasc Thorac Surg. 2022 May 2;34(5):760-767. doi: 10.1093/icvts/ivac011. Interact Cardiovasc Thorac Surg. 2022. PMID: 35147676 Free PMC article.
-
Measures to accelerate recovery from stage III tuberculous empyema: tuberculous empyema surgical and recovery methods.Perioper Med (Lond). 2025 Apr 17;14(1):43. doi: 10.1186/s13741-025-00530-y. Perioper Med (Lond). 2025. PMID: 40247419 Free PMC article.
References
-
- Tuberculous empyema thoracis: clinical, bacteriological features and its medical management. Prakash B, Khare P, Bhatnagar AK. http://www.ijss-sn.com/uploads/2/0/1/5/20153321/ijss_sep_oa27.pdf Int J Sci Study. 2015;3:120–125.
-
- Iguina MM, Danckers M. Treasure Island: StatPearls; 2020. Thoracic Empyema. - PubMed
-
- Clinical characteristics and outcomes of empyema thoracis in 117 patients: a comparative analysis of tuberculous vs. non-tuberculous aetiologies. Malhotra P, Aggarwal AN, Agarwal R, Ray P, Gupta D, Jindal SK. Respir Med. 2007;101:423–430. - PubMed
-
- Global Tuberculosis Report 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-en... 2020
LinkOut - more resources
Full Text Sources
Other Literature Sources